Patel Nimesh A, Gangasani Nikitha, Yannuzzi Nicolas A, Melo Gustavo, Flynn Harry W, Smiddy William E
Ophthalmic Surg Lasers Imaging Retina. 2019 Aug 1;50(8):504-508. doi: 10.3928/23258160-20190806-05.
To describe the reasons for and clinical outcomes of intraocular lens (IOL) removal, with or without exchange, in the setting of retina surgery.
This is a retrospective, noncomparative, consecutive, interventional case series of patients undergoing IOL removal at an academic referral center performed by a single surgeon between 2002 and 2013. Data collected included baseline patient characteristics, visual acuity (VA), type of IOL, reason for IOL removal, and postoperative complications.
The study cohort included 63 eyes with IOL removal. Of these, 51 (81%) were left aphakic. For cases of IOL opacification or dislocated IOL (56), the decision to remove was made for 35 (63%) during concurrent retinal surgery due to obstruction in visualization. Overall, the most common reason for removal of the IOL was IOL opacities in 42 eyes (67%), followed by nonspecific nature of opacities (n = 19; 45%), oil artifact (n = 17; 40%), opaque nonvascular membranes (n = 4; 10%), and fibrovascular proliferation (n = 2; 5%). Other causes for removal were IOL dislocation (n = 14; 22%), endophthalmitis (n = 7; 11%), and broken IOL haptic (n = 1; 2%). The composition of the 42 IOLs with opacification included 19 (45%) silicone, 14 (33%) unspecified, five (12%) polymethyl methacrylate, and four acrylic (10%). From the 17 IOLs removed due to oil opacification, 15 (83%) were silicone, and two (17%) were unspecified. Postoperative complications included recurrent retinal detachment (n = 13; 21%), hypotony (n = 8; 13%), phthisis bulbi (n = 8; 13%), corneal edema (n = 7; 11%), cystoid macular edema (n = 5; 8%), elevated intraocular pressure (n = 3; 5%), vitreous hemorrhage (n = 3; 5%), hyphema (1; 2%), anterior synechiae (1; 2%), and subretinal hemorrhage (1; 2%) The mean (SD) immediate, 3 months, and final best-corrected VA in logMAR were 2.18 (0.47), 1.85 (0.82), and 1.97 (0.85).
The vitreoretinal surgeon must be prepared for IOL removal, especially if IOL opacification and dislocation compromise the view or capability to achieve primary retinal reattachment objectives. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:504-508.].
描述视网膜手术中人工晶状体(IOL)取出(无论是否进行置换)的原因及临床结果。
这是一项回顾性、非对照、连续性、干预性病例系列研究,研究对象为2002年至2013年间在一家学术转诊中心由同一位外科医生进行IOL取出手术的患者。收集的数据包括患者基线特征、视力(VA)、IOL类型、IOL取出原因及术后并发症。
研究队列包括63只接受IOL取出手术的眼。其中,51只(81%)术后变为无晶状体眼。对于IOL混浊或脱位的病例(56例),35例(63%)因术中妨碍视野而在同期视网膜手术时决定取出IOL。总体而言,IOL取出最常见的原因是42只眼(67%)的IOL混浊,其次是混浊的非特异性性质(n = 19;45%)、硅油伪像(n = 17;40%)、不透明无血管膜(n = 4;10%)和纤维血管增殖(n = 2;5%)。其他取出原因包括IOL脱位(n = 14;22%)、眼内炎(n = 7;11%)和IOL襻断裂(n = 1;2%)。42只发生混浊的IOL的组成包括19只(45%)硅凝胶、14只(33%)未明确类型、5只(12%)聚甲基丙烯酸甲酯和4只丙烯酸酯(10%)。在因硅油混浊而取出的17只IOL中,15只(83%)是硅凝胶,2只(17%)未明确类型。术后并发症包括复发性视网膜脱离(n = 13;21%)、低眼压(n = 8;13%)、眼球痨(n = 8;13%)、角膜水肿(n = 7;11%)、黄斑囊样水肿(n = 5;8%)、眼压升高(n = 3;5%)、玻璃体积血(n = 3;5%)、前房积血(1;2%)、虹膜前粘连(1;2%)和视网膜下出血(1;2%)。以logMAR表示的平均(标准差)即时、3个月和最终最佳矫正视力分别为2.18(0.47)、1.85(0.82)和1.97(0.85)。
玻璃体视网膜外科医生必须为IOL取出做好准备,尤其是当IOL混浊和脱位影响视野或实现视网膜初次复位目标的能力时。[《眼科手术、激光与影像学杂志》。2019;50:504 - 508。]